EZH1 in germ cells safeguards the function of PRC2 during spermatogenesis

被引:33
|
作者
Mu, Weipeng
Starmer, Joshua
Shibata, Yoichiro
Yee, Della
Magnuson, Terry [1 ]
机构
[1] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
EZH1; EZH2; Polycomb-Group protein; Histone methylation; Enhancer; Spermatogenesis; STEM-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MALE MEIOSIS; POLYCOMB; COMPLEX; METHYLATION; DIFFERENTIATION; CHROMATIN; ENHANCER;
D O I
10.1016/j.ydbio.2017.02.017
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We previously reported the requirement of Polycomb Repressive Complex 2 (PRC2) for spermatogenesis through transcriptional repression of somatic genes and meiosis-specific genes. To characterize how PRC2's two methyltransferase subunits, EZH1 and EZH2, regulate histone H3 lysine 27 (H3K27) methylation during germ. cell development, we generated mouse models with a germline ablation of EZH1 and/or EHZ2. Only the combined loss of EZH1 and EZH2 caused a depletion of global H3K27me3 marks and meiotic arrest in spermatocytes. Genome-wide analysis of H3K27me3 in spermatogenic cells revealed that a noncanonical EZH1-PRC2 could establish and maintain this histone mark on somatic genes and certain meiotic genes. Consistent with it having active enhancers in testis, Ezh1 was not only abundant in highly differentiated spermatocytes but also in actively proliferating progenitor and stem germ cells. Taken together, our findings suggest that the expression level of Ezhl determines the restoration of H3K27 methylation in the absence of the canonical EZH2-PRC2.
引用
收藏
页码:198 / 207
页数:10
相关论文
共 50 条
  • [31] Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression
    Yoshida, Kazuhiro
    Toden, Shusuke
    Ravindranathan, Preethi
    Han, Haiyong
    Goel, Ajay
    CARCINOGENESIS, 2017, 38 (10) : 1036 - 1046
  • [32] Engaging chromatin: PRC2 structure meets function
    Chammas, Paul
    Mocavini, Ivano
    Di Croce, Luciano
    BRITISH JOURNAL OF CANCER, 2020, 122 (03) : 315 - 328
  • [33] EZH1/2 as targets for cancer therapy
    An, Ran
    Li, Yu-Qing
    Lin, Yue-Ling
    Xu, Fang
    Li, Man-Mei
    Liu, Zhong
    CANCER GENE THERAPY, 2023, 30 (02) : 221 - 235
  • [34] A PRC2 independent role of EZH2 in androgen receptor signaling in prostate cancer
    Lee, Yongik
    Kim, Jung A.
    Zhao Changsheng
    Lu, Xiadong
    Fong, Ka Wing
    Yu, Jindan
    CANCER RESEARCH, 2018, 78 (13)
  • [35] An Evolutionarily Conserved Structural Platform for PRC2 Inhibition by a Class of Ezh2 Inhibitors
    Matthew Bratkowski
    Xin Yang
    Xin Liu
    Scientific Reports, 8
  • [36] An Evolutionarily Conserved Structural Platform for PRC2 Inhibition by a Class of Ezh2 Inhibitors
    Bratkowski, Matthew
    Yang, Xin
    Liu, Xin
    SCIENTIFIC REPORTS, 2018, 8
  • [37] Ezh1 arises from Ezh2 gene duplication but its function is not required for zebrafish development
    Volkel, Pamela
    Bary, Aurelie
    Raby, Ludivine
    Chapart, Anais
    Dupret, Barbara
    Le Bourhis, Xuefen
    Angrand, Pierre-Olivier
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [38] Ezh1 arises from Ezh2 gene duplication but its function is not required for zebrafish development
    Pamela Völkel
    Aurélie Bary
    Ludivine Raby
    Anaïs Chapart
    Barbara Dupret
    Xuefen Le Bourhis
    Pierre-Olivier Angrand
    Scientific Reports, 9
  • [39] PRC2 shields the potency of human stem cells
    Aranda, Sergi
    Condemi, Livia
    Di Croce, Luciano
    NATURE CELL BIOLOGY, 2022, 24 (06) : 806 - 808
  • [40] Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2
    Liu, Zhihao
    Hu, Xi
    Wang, Qiwei
    Wu, Xiuli
    Zhang, Qiangsheng
    Wei, Wei
    Su, Xingping
    He, Hualong
    Zhou, Shuyan
    Hu, Rong
    Ye, Tinghong
    Zhu, Yongxia
    Wang, Ningyu
    Yu, Luoting
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (05) : 2829 - 2848